Someone else's clock has started running against them: the company is being paid to solve a problem that is already cost
The model's full reasoning — Q2 2017 call → NOWe need to answer YES or NO based on the transcript. The question asks: Does management describe that its counterparties (customers, partners) are already losing something real and ongoing for as long as they do not have what the company provides, and that this accumulating loss is already visible in how those parties are behaving toward the company today? Also, management should convey that this dynamic is generating business meaningful relative to company size and whose contribution is still largely ahead. We need to find in the transcript where management describes customers or partners in a situation where they are incurring ongoing losses because they lack the company's product, and are already acting urgently because of that. The transcript covers Biogen's earnings call. It discusses MS franchise, SPINRAZA for SMA, biosimilars, pipeline, etc. We need to see if any of these descriptions fit the "running meter" concept. Let's scan the call. The CEO, Michel, discusses MS, SPINRAZA, biosimilars. The discussion about SPINRAZA: they talk about patients with SMA, and the drug is a treatment. They describe high demand, uptake, etc. But do they describe that patients (or payers) are losing something ongoing because they don't have SPINRAZA? They talk about patients being motivated, demand, but they don't explicitly frame it as a running meter of cost or loss for the counterparty. They mention that SMA is a devastating disease, and that patients need treatment, but they don't describe a concrete accumulating loss that stops only when the company delivers. They talk about infrastructure, sites, coverage, but not about counterparties incurring losses while they wait. For MS, they discuss market growth, competition, but not a running meter. Biosimilars: They talk about providing savings, but not a running loss. Look at the strategic update: They talk about unmet needs, but not a specific counterparty losing something. The question is very specific: a "running meter" where the counterparty is losing something real, and they are acting urgently because of it. The transcript might have something about patients not being able to access SPINRAZA? They talk about spinal surgery challenges, but that's about administration difficulty, not about the customer losing something.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
SYM · Q3 2022 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...YES The transcript shows management describing customers' ongoing pain from labor shortages and broken supply chains that prevent them from handling demand, with customers actively clamoring for faster deployments and wanting the system as quickly as possible.
CRL · Q2 2022 → YESThe question is whether management describes that their counterparties are already losing something real and ongoing — money, output, access, standing, time, or an opportunity — for as long as they do...
GTES · Q4 2021 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...